ARS Pharmaceuticals Inc — Cash Flow (NASDAQ:SPRY) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 66.76 M40.08 M59.27 M13.55 M 112.47 M Cash from investing activities 66.48 M199 K87.18 M106.1 M 134.41 M Cash from financing activities 614 K190.73 M6.9 M72.4 M 174.38 M Free cash flow 65.39 M39.88 M59.09 M12.98 M 111.83 M

Notícias

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

China aprova primeiro spray nasal de epinefrina para alergias de uso comunitário

China approves first community use epinephrine nasal spray for allergies

Diretor de negócios da ARS Pharma vende ações no valor de US$ 1,47 milhões

Dorsey, diretor de operações da ARS Pharma, vende US$ 190 mil em ações SPRY

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript

Ações da ARS Pharmaceuticals sobem com fortes vendas no 3º tri, Raymond James reitera forte compra

ARS Pharmaceuticals tem classificação "Outperform" reafirmada pelo William Blair com base em dados do neffy